Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Working Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 3.963.192.692.662.94

What is the latest Working Capital/Sales ratio of NGL FINECHEM ?

The latest Working Capital/Sales ratio of NGL FINECHEM is 3.96 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20263.96
Mar20253.19
Mar20242.69
Mar20232.66
Mar20222.94

How is Working Capital/Sales of NGL FINECHEM Trending?

Years Working Capital/Sales % Change
Mar2026 3.96
24.14
Mar2025 3.19
18.59
Mar2024 2.69
1.13
Mar2023 2.66
-9.52
Mar2022 2.94 -

Other Financial Ratios of NGL FINECHEM


Compare Working Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹2,144.9 Cr 0.5% 9.4% 162.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,471.0 Cr -0.5% 0.8% 19% Stock Analytics
DIVIS LABORATORIES ₹226,631.0 Cr 2.2% 23.1% 27.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,157.0 Cr -2.6% -1.6% 36% Stock Analytics
CIPLA ₹118,108.0 Cr 0.8% 2.5% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,578.0 Cr 2.6% -2.4% -5.6% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

0.5%

9.4%

162.9%

SENSEX

-0.4%

0.8%

-3%


You may also like the below Video Courses